Dutasteride Patent Expiration
Dutasteride is used for treating benign prostatic hyperplasia and other androgen-responsive conditions by inhibiting the 5 alpha testosterone reductase enzyme with dutasteride or its derivatives. It was first introduced by Waylis Therapeutics Llc
Dutasteride Patents
Given below is the list of patents protecting Dutasteride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Avodart | US5565467 | Androstenone derivative |
Nov 20, 2015
(Expired) | Waylis Therap |
| Avodart | US5846976 | Androstenone derivative |
Sep 17, 2013
(Expired) | Waylis Therap |
| Avodart | US5998427 | Androstenones |
Sep 17, 2013
(Expired) | Waylis Therap |
Dutasteride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List